Skip to Content

WPI 2232 (Tamoxifen 10 mg)

This pill with imprint "WPI 2232" is White, Round and has been identified as Tamoxifen citrate 10 mg. It is manufactured by Watson Pharmaceuticals, Inc..

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, metastatic; breast cancer, male; mccune-albright syndrome (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate 10 mg WPI 2232
Tamoxifen citrate
WPI 2232
10 mg
Prescription only
Drug Class:
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Watson Pharmaceuticals, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.